Real-world experience of ocrelizumab in multiple sclerosis in a Spanish population.
Fernandez-Diaz E, Perez-Vicente JA, Villaverde-Gonzalez R, Berenguer-Ruiz L, Candeliere Merlicco A, Martinez-Navarro ML, Gracia Gil J, Romero-Sanchez CM, Alfaro-Saez A, Diaz I, Gimenez-Martinez J, Mendez-Miralles MA, Millan-Pascual J, Jimenez-Pancho J, Mola S, Sempere AP.
Fernandez-Diaz E, et al. Among authors: gimenez martinez j.
Ann Clin Transl Neurol. 2021 Feb;8(2):385-394. doi: 10.1002/acn3.51282. Epub 2020 Dec 25.
Ann Clin Transl Neurol. 2021.
PMID: 33369288
Free PMC article.